Caixin
Oct 29, 2022 08:00 AM

Yantai Dongcheng Biochemicals Co.,Ltd.’s Net Profit Rose 10.2% in First Three Quarters of 2022

00:00
00:00/00:00
Listen to this article 1x

Yantai Dongcheng Biochemicals Co.,Ltd. (烟台东诚药业集团股份有限公司) (002675.SZ) reported a net profit of 382.8 million yuan in the first three quarters of 2022, up 10.2% year-on-year.

Meanwhile, the company posted 2.7 billion yuan in revenue, down 1.9% year-on-year.

At the end of the reporting period, it had 8.5 billion yuan in total assets and 2.8 billion yuan in total liabilities, with a liability-to-asset ratio of 32.9%.

Unlock exclusive discounts with a Caixin group subscription — ideal for teams and organizations.

Subscribe to both Caixin Global and The Wall Street Journal — for the price of one.

Share this article
Open WeChat and scan the QR code
NEWSLETTERS
Get our CX Daily, weekly Must-Read and China Green Bulletin newsletters delivered free to your inbox, bringing you China's top headlines.

We ‘ve added you to our subscriber list.

Manage subscription
PODCAST